Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomized Comparison Clinical Trial of Target Activated CIK for Advanced Breast Cancer

NCT03524261 is registered in ClinicalTrials.gov with Fuda Cancer Hospital, Guangzhou as lead sponsor.

NCT NCT03524261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03524261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomized Comparison Clinical Trial of Target Activated CIK for Advanced Breast Cancer
Lead sponsor
Fuda Cancer Hospital, Guangzhou
Phase
Phase 2
Overall status
Withdrawn
Start date
May 20, 2019
Completion date
July 5, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer